July 9, 2019
Eisai said on July 8 that it has sealed a research collaboration pact with the University of Dundee in Scotland, aiming to discover cancer drug candidates based on Proteolysis Targeting Chimera (PROTAC) technologies. PROTACs recruit an ubiquitin E3 ligase to...read more